Algo version: 0.98b
Innovator IBD Breakout is listed at the NYSE Exchange
Innovator IBD Breakout [BOUT]
NYSE Sector: Financial Services Industry:Asset Management

Is Innovator IBD Breakout stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Innovator IBD Breakout pays dividends. Last time was Thursday 1st of August 2024 where the investors holding the stock on Wednesday 31st of July 2024 were paid $0.0059 per share. Over the last 4 times between 2018 and 2024, Innovator IBD Breakout has paid $0.88094 with an average of $0.22 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Innovator IBD Breakout 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $20.20, you would have made a profit of $14.73 per share or 72.92%

No, the average daily trading liquidity for Innovator IBD Breakout is $1 425 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Innovator IBD Breakout has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Innovator IBD Breakout to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.